Irpagratinib
- Generic Name
- Irpagratinib
FGF19 Overexpression Combination Unified Study in HCC-19
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT06978933
- Locations
- 🇨🇳
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath